HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS • US4330001060
14.52 USD
-1.08 (-6.92%)
At close: Feb 27, 2026
14.55 USD
+0.03 (+0.21%)
After Hours: 2/27/2026, 8:04:00 PM
Overall HIMS gets a fundamental rating of 4 out of 10. We evaluated HIMS against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HIMS while its profitability can be described as average. HIMS is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year HIMS was profitable.
- HIMS had a positive operating cash flow in the past year.
- HIMS had negative earnings in 4 of the past 5 years.
- In multiple years HIMS reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 5.99%, HIMS belongs to the top of the industry, outperforming 82.18% of the companies in the same industry.
- With an excellent Return On Equity value of 23.03%, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
- With a decent Return On Invested Capital value of 5.84%, HIMS is doing good in the industry, outperforming 62.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of HIMS (6.05%) is better than 82.18% of its industry peers.
- With a decent Operating Margin value of 5.96%, HIMS is doing good in the industry, outperforming 66.34% of the companies in the same industry.
- HIMS has a better Gross Margin (75.01%) than 90.10% of its industry peers.
- HIMS's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HIMS is destroying value.
- HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- HIMS has an Altman-Z score of 2.60. This is not the best score and indicates that HIMS is in the grey zone with still only limited risk for bankruptcy at the moment.
- HIMS has a Altman-Z score (2.60) which is comparable to the rest of the industry.
- HIMS has a debt to FCF ratio of 8.13. This is a slightly negative value and a sign of low solvency as HIMS would need 8.13 years to pay back of all of its debts.
- HIMS has a Debt to FCF ratio (8.13) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
- HIMS has a worse Debt to Equity ratio (1.67) than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 2.6 |
ROIC/WACC0.67
WACC8.66%
2.3 Liquidity
- A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
- HIMS's Current ratio of 1.88 is fine compared to the rest of the industry. HIMS outperforms 78.22% of its industry peers.
- A Quick Ratio of 1.64 indicates that HIMS should not have too much problems paying its short term obligations.
- HIMS has a Quick ratio of 1.64. This is in the better half of the industry: HIMS outperforms 68.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- HIMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.41%.
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
3.2 Future
- Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 51.33% on average per year.
- The Revenue is expected to grow by 12.27% on average over the next years. This is quite good.
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 29.04, the valuation of HIMS can be described as expensive.
- The rest of the industry has a similar Price/Earnings ratio as HIMS.
- Compared to an average S&P500 Price/Earnings ratio of 27.10, HIMS is valued at the same level.
- The Price/Forward Earnings ratio is 24.97, which indicates a rather expensive current valuation of HIMS.
- HIMS's Price/Forward Earnings ratio is in line with the industry average.
- HIMS's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.06.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.04 | ||
| Fwd PE | 24.97 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.66 | ||
| EV/EBITDA | 20.71 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of HIMS may justify a higher PE ratio.
- A more expensive valuation may be justified as HIMS's earnings are expected to grow with 68.86% in the coming years.
PEG (NY)1.78
PEG (5Y)N/A
EPS Next 2Y26.07%
EPS Next 3Y68.86%
5. Dividend
5.1 Amount
- No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
14.52
-1.08 (-6.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners94.2%
Inst Owner Change-9.84%
Ins Owners5.93%
Ins Owner Change-1.34%
Market Cap3.31B
Revenue(TTM)N/A
Net Income(TTM)133.79M
Analysts67.27
Price Target30 (106.61%)
Short Float %37.45%
Short Ratio3.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-2.29%
PT rev (3m)-11.57%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-32.54%
EPS NY rev (1m)0.73%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.04 | ||
| Fwd PE | 24.97 | ||
| P/S | 1.5 | ||
| P/FCF | 27.66 | ||
| P/OCF | 10.17 | ||
| P/B | 5.69 | ||
| P/tB | 26.07 | ||
| EV/EBITDA | 20.71 |
EPS(TTM)0.5
EY3.44%
EPS(NY)0.58
Fwd EY4%
FCF(TTM)0.52
FCFY3.61%
OCF(TTM)1.43
OCFY9.83%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)1.78
PEG (5Y)N/A
Graham Number5.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 2.6 |
F-Score3
WACC8.66%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.34%
EBIT Next 3Y88.26%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 4 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Fairly Valued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.